Filters

Test type

Test purpose

Test method

Test service

Laboratory certification

Specimen type

See more specimen types...

Laboratory location

Other countries

Results: 1 to 20 of 28

Tests names and labsConditionsGenes, analytes, and microbesMethods

RECQL Gene Breast cancer, susceptibility to NGS Genetic DNA Test

DNA Labs India
India
11
  • S Mutation scanning of the entire coding region

Comprehensive cancer panel (76 genes)

Molecular Genetics Laboratory North York General Hospital
Canada
174
  • T Targeted variant analysis

OncoAlly™ Comprehensive Hereditary Cancer Analysis

Variantyx, Inc.
United States
188
  • D Deletion/duplication analysis
  • X Mutation scanning of select exons
  • C Sequence analysis of the entire coding region

CancerNext® 37

Ambry Genetics
United States
7937
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Penn Cancer Grant Panel

Ambry Genetics
United States
7980
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Hereditary Cancer Targeted Variant Analysis

Molecular Genetics Laboratory North York General Hospital
Canada
174
  • T Targeted variant analysis

Hereditary Lymphoid/Immunodeficiency Predisposition Panel

Genetic Services Laboratory University of Chicago
United States
2766
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Cancer Panel

PreventionGenetics, part of Exact Sciences
United States
122117
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Breast Cancer - Expanded Risk Panel

PreventionGenetics, part of Exact Sciences
United States
1621
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Gynecological (Breast, Ovarian, Endometrial) Cancer Panel 

CGC Genetics Unilabs
Portugal
136
  • C Sequence analysis of the entire coding region

Endocrine Neoplasia Panel (Expanded)

Mendelics
Brazil
158
  • C Sequence analysis of the entire coding region

Hereditary Cancer Panel

Mendelics
Brazil
137
  • C Sequence analysis of the entire coding region

Melanoma and Other Skin Cancers Panel

Mendelics
Brazil
144
  • C Sequence analysis of the entire coding region

Endocrine Neoplasia Panel

Mendelics
Brazil
141
  • C Sequence analysis of the entire coding region

Hereditary Breast Cancer and Ovarian Cancer

Mendelics
Brazil
137
  • C Sequence analysis of the entire coding region

Hereditary Cancer Panel (Complete)

Mendelics
Brazil
1264
  • C Sequence analysis of the entire coding region

Hereditary Colorectal Cancer Panel

Mendelics
Brazil
142
  • C Sequence analysis of the entire coding region

HEREDITARY CANCER EXOME PANEL

Laboratorio de Genetica Clinica SL
Spain
1249
  • E Sequence analysis of select exons

BREAST AND OVARIAN CANCER EXOME PANEL

Laboratorio de Genetica Clinica SL
Spain
148
  • E Sequence analysis of select exons

Hereditary Cancer Testing - Full Panel (76) AIP, APC, ATM, AXIN2, BAP1, BARD1, BMPR1A, BRCA1, BRCA2, BRIP1, CDC73, CDH1, CDK4, CDKN1B, CDKN2A, CHEK2, CTNN1, DICER1, EGFR, EGLN1, EPCAM, EXT1, EXT2, FH, FLCN, GALNT12, GREM1, HOXB13, KIT, LZTR1, MAX, MEN1, M

Diagnostic Medical Genetics Mount Sinai Hospital, Sinai Health System
Canada
178
  • S Mutation scanning of the entire coding region

Results: 1 to 20 of 28

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.